Meeting
2020 ASCO Virtual Scientific Program
Complete human papillomavirus vaccination coverage over a 13-year period in a large population of privately insured U.S. patients.
Authors
Yull Edwin Arriaga
University of Texas Southwestern Medical Center, Dallas, TX
Yull Edwin Arriaga , Bedda L Rosario , Elisabeth Scheufele , Amol Rajmane , Brett South , Sarah Kefayati , Judy George , Timothy Bullock , Gretchen Purcell Jackson , Kyu Rhee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1511)
DOI
10.1200/JCO.2020.38.15_suppl.1511
Abstract #
1511
Poster Bd #
3
Abstract Disclosures
Similar Posters
First Author: Thanuja Neerukonda
Poster
2023 ASCO Annual Meeting
Efficacy and safety of combining PD-1 blockage and human papillomavirus vaccine for patients with relapsed/refractory advanced cervical cancer.
First Author: Buhai Wang
Poster
2022 ASCO Annual Meeting
Human papillomavirus (HPV) vaccine hesitancy trends in the United States.
First Author: Eric Adjei Boakye
Poster
2022 ASCO Annual Meeting
The role of health information technology in improving awareness of HPV and HPV vaccine among U.S. adults: Insights from the health information national trends survey.
First Author: Gideon T Dosunmu